Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12281-020-00409-z http://scihub22266oqcxt.onion/10.1007/s12281-020-00409-z 33312332!7717101!33312332     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Fungal+Infect+Rep 2020 ; 14 (4): 378-383 Nephropedia Template TP {{tp|p=33312332|t=2020. The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update |pdf=|usr=}}{{33312332}} gab.com Text The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update JO: Curr Fungal Infect Rep http://www.kidney.de/pget.php?&tw=1&pmid=33312332 #FOAvip PURPOSE OF REVIEW: To review the data on the Aspergillus lateral flow assay for the diagnosis of invasive Aspergillosis. RECENT FINDINGS: Aspergillus spp. cause a wide spectrum of disease with invasive aspergillosis (IA) as its most severe manifestation. Early and reliable diagnosis of disease is crucial to decrease associated morbidity and mortality, and enable prompt initiation of treatment for IA. Most recently, non-culture-based tests, such as Aspergillus galactomannan (GM), have been useful in early identification and treatment of patients with IA. However, cost, turnaround time, and variable performance indifferent populations at risk for IA remain significant drawbacks to the use of this test. Several diagnostic tests for IA have been developed, including the sona Aspergillus GM Lateral flow assay (GM-LFA) rapid test. SUMMARY: The GM-LFA has shown excellent performance for the diagnosis of IA in patients with hematologic malignancy and may be a viable option for settings where ELISA GM testing is not feasible. Further evaluation of the GM-LFA in the non-hematology setting is ongoing, including in solid organ transplant recipients and patients in the intensive care unit. Twit Text FOAVip The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update ????Curr Fungal Infect Rep http://www.kidney.de/pget.php?&tw=1&pmid=33312332 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33312332 #FOAvip English Wikipedia <ref>{{Cite pmid|33312332}}</ref> The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update #MMPMID33312332 Jenks JD; Miceli MH; Prattes J; Mercier T; Hoenigl M Curr Fungal Infect Rep 2020[]; 14 (4): 378-383 PMID33312332show ga PURPOSE OF REVIEW: To review the data on the Aspergillus lateral flow assay for the diagnosis of invasive Aspergillosis. RECENT FINDINGS: Aspergillus spp. cause a wide spectrum of disease with invasive aspergillosis (IA) as its most severe manifestation. Early and reliable diagnosis of disease is crucial to decrease associated morbidity and mortality, and enable prompt initiation of treatment for IA. Most recently, non-culture-based tests, such as Aspergillus galactomannan (GM), have been useful in early identification and treatment of patients with IA. However, cost, turnaround time, and variable performance indifferent populations at risk for IA remain significant drawbacks to the use of this test. Several diagnostic tests for IA have been developed, including the sona Aspergillus GM Lateral flow assay (GM-LFA) rapid test. SUMMARY: The GM-LFA has shown excellent performance for the diagnosis of IA in patients with hematologic malignancy and may be a viable option for settings where ELISA GM testing is not feasible. Further evaluation of the GM-LFA in the non-hematology setting is ongoing, including in solid organ transplant recipients and patients in the intensive care unit. äThe Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Asper(epmc).pdf DeepDyve Pubget Overpricing